Evidence map›Paper›PMID 29484460›Full record

ReviewDer Urologe. Ausg. A2018

[Human papillomavirus and penile cancer : Thinking about measures for prevention].

P Schneede, B Schlenker

Abstract readReview
PubMed Publisher
In one paragraph

Review in Der Urologe. Ausg. A, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.9field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 9 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Review
  5. [Penile cancer: diagnosis and staging].Der Urologe. Ausg. A · 2018
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 1 country.

P SchneedeUrologische Klinik, Klinikum Memmingen, Bismarckstraße 23, 87700, Memmingen, Deutschland. Peter.Schneede@klinikum-memmingen.de.
B SchlenkerKlinikum der Universität München, Großhadern, München, Deutschland.
Kernkraftwerk Gundremmingen · DELMU Klinikum · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Two major pathways of penile carcinogenesis are known: human papillomavirus (HPV)-induced penile cancer and HPV-negative cancers associated with chronic dermatoses. Therefore, modern measures for prevention of penile cancer may for example include prophylactic HPV vaccination. The resulting B‑cell-mediated immunity to HPV capsid proteins is effective protection against future HPV infections. Contrarily when treating existing HPV infections or HPV-associated cancers an antigen-specific T‑cell immunity is necessary. To date, screening and treatment of precancerous lesions to prevent penile cancer are not established in the German health care program and the highly expected therapeutic HPV vaccines are still on the horizon. In this article, we focus on possible strategies to prevent HPV-related penile cancer on different levels of carcinogenesis.

Indexed as

Carcinoma, Squamous CellCircumcision, MaleEarly Detection of CancerEarly DiagnosisEpitopesHumansMalePapillomaviridaePapillomavirus InfectionsPapillomavirus VaccinesPenile NeoplasmsPenisPhimosisPrecancerous ConditionsT-LymphocytesEpitopesPapillomavirus VaccinesCancer screeningPhimosisPreventionSquamous cell carcinomaVaccination

Identifiers

PMID29484460
OpenAlexW2791773883

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.